NYLEX Stock Overview
Nylex (Malaysia) Berhad, an investment holding company, manufactures, markets, and distributes petrochemicals and industrial chemical products.
Nylex (Malaysia) Berhad Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||RM0.20|
|52 Week High||RM1.88|
|52 Week Low||RM0.17|
|1 Month Change||-17.02%|
|3 Month Change||-33.90%|
|1 Year Change||-80.00%|
|3 Year Change||-68.03%|
|5 Year Change||-79.37%|
|Change since IPO||-94.87%|
Recent News & Updates
|NYLEX||MY Chemicals||MY Market|
Return vs Industry: NYLEX underperformed the MY Chemicals industry which returned -1.5% over the past year.
Return vs Market: NYLEX underperformed the MY Market which returned -10.2% over the past year.
|NYLEX Average Weekly Movement||10.0%|
|Chemicals Industry Average Movement||5.3%|
|Market Average Movement||5.2%|
|10% most volatile stocks in MY Market||11.3%|
|10% least volatile stocks in MY Market||2.4%|
Stable Share Price: NYLEX is more volatile than 75% of MY stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: NYLEX's weekly volatility has decreased from 21% to 10% over the past year, but is still higher than 75% of MY stocks.
About the Company
|n/a||n/a||Ka Wei Siew||https://www.nylex.com|
Nylex (Malaysia) Berhad, an investment holding company, manufactures, markets, and distributes petrochemicals and industrial chemical products. The company operates through Polymer, Industrial Chemical, and Logistics segments. The Polymer segment manufactures and markets polyvinyl chloride and polyurethane leather cloths, films and sheets, pre-fabricated drains, bulk chemical containers, road barriers, rubbish bins, playground equipment, water tanks, and other custom moldings for use in furniture, automotive, building interiors, industrial laminates, medical, and stationery markets.
Nylex (Malaysia) Berhad Fundamentals Summary
|NYLEX fundamental statistics|
Is NYLEX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NYLEX income statement (TTM)|
|Cost of Revenue||RM853.21m|
Last Reported Earnings
May 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.28|
|Net Profit Margin||-5.40%|
How did NYLEX perform over the long term?See historical performance and comparison
Is NYLEX undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NYLEX?
Other financial metrics that can be useful for relative valuation.
|What is NYLEX's n/a Ratio?|
Price to Sales Ratio vs Peers
How does NYLEX's PS Ratio compare to its peers?
|NYLEX PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
SERSOL Sersol Berhad
TOYOVEN Toyo Ventures Holdings Berhad
TECHBND Techbond Group Berhad
ARTRONIQ Artroniq Berhad
NYLEX Nylex (Malaysia) Berhad
Price-To-Sales vs Peers: NYLEX is good value based on its Price-To-Sales Ratio (0x) compared to the peer average (1.7x).
Price to Earnings Ratio vs Industry
How does NYLEX's PE Ratio compare vs other companies in the MY Chemicals Industry?
Price-To-Sales vs Industry: NYLEX is good value based on its Price-To-Sales Ratio (0x) compared to the MY Chemicals industry average (1.3x)
Price to Sales Ratio vs Fair Ratio
What is NYLEX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||0.04x|
|Fair PS Ratio||n/a|
Price-To-Sales vs Fair Ratio: Insufficient data to calculate NYLEX's Price-To-Sales Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of NYLEX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate NYLEX's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate NYLEX's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Nylex (Malaysia) Berhad forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Materials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nylex (Malaysia) Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Examine Nylex (Malaysia) Berhad's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
How has Nylex (Malaysia) Berhad performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NYLEX is currently unprofitable.
Growing Profit Margin: NYLEX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: NYLEX is unprofitable, and losses have increased over the past 5 years at a rate of 45.5% per year.
Accelerating Growth: Unable to compare NYLEX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NYLEX is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (13.1%).
Return on Equity
High ROE: NYLEX has a negative Return on Equity (-218.62%), as it is currently unprofitable.
Discover strong past performing companies
How is Nylex (Malaysia) Berhad's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: NYLEX's short term assets (MYR15.7M) exceed its short term liabilities (MYR680.0K).
Long Term Liabilities: NYLEX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: NYLEX is debt free.
Reducing Debt: NYLEX has no debt compared to 5 years ago when its debt to equity ratio was 72.7%.
Debt Coverage: NYLEX has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: NYLEX has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies
What is Nylex (Malaysia) Berhad current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NYLEX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NYLEX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NYLEX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NYLEX's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: NYLEX is not paying a notable dividend for the MY market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as NYLEX has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ka Wei Siew (66 yo)
Dato? Ka Wei Siew has been Executive Chairman of Ancom Nylex Berhad (formerly known as Ancom Berhad) since January 2, 2018 and has been its Director since October 23, 1985. Dato?Siew served as Group Manag...
CEO Compensation Analysis
Compensation vs Market: Ka Wei's total compensation ($USD284.31K) is above average for companies of similar size in the MY market ($USD108.46K).
Compensation vs Earnings: Ka Wei's compensation has increased whilst the company is unprofitable.
Experienced Management: NYLEX's management team is seasoned and experienced (14.7 years average tenure).
Experienced Board: NYLEX's board of directors are seasoned and experienced ( 16.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Nylex (Malaysia) Berhad's employee growth, exchange listings and data sources
- Name: Nylex (Malaysia) Berhad
- Ticker: NYLEX
- Exchange: KLSE
- Founded: NaN
- Industry: Specialty Chemicals
- Sector: Materials
- Implied Market Cap: RM35.059m
- Shares outstanding: 179.79m
- Website: https://www.nylex.com
- Nylex (Malaysia) Berhad
- Lot 16
- Persiaran Selangor
- Shah Alam
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|NYLEX||KLSE (Bursa Malaysia)||Yes||Ordinary Shares||MY||MYR||Jan 1992|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/09/25 00:00|
|End of Day Share Price||2022/09/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.